(Q70712589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Phase I evaluation of AT-125 single dose every three weeks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

S Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R J Belt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

U Joseph

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

C D Haas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

B Hoogstraten

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

311-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00175382

13 October 2019

exact match

0 references

cites work

Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease

1 reference

12 December 2020

Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity

1 reference

12 December 2020

L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys.

1 reference

12 December 2020

Phase I and pharmacokinetic studies of DON

1 reference

12 December 2020

Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00175382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6511237%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference